Eva Huber

Dr. Eva Huber


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2012 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
EHEva Huber
Eva Huber
MGMichael Groll
Michael Groll

11 March 2016 in Nature Communications
Verified
Journal Article
Open access
EHEva Huber
Eva Huber
WHWolfgang Heinemeyer
Wolfgang Heinemeyer
XLXia Li
Xia Li
CACassandra S. Arendt
Cassandra S. Arendt
MHMark Hochstrasser
Mark Hochstrasser
MGMichael Groll
Michael Groll
Biogenesis of the 20S proteasome is tightly regulated. The N-terminal propeptides protecting the active-site threonines are autocatalytically released only on completion of assembly. However, the trigger for the self-activation and the reason for the strict conservation of threonine as the active site nucleophile remain enigmatic. Here we use mutagenesis, X-ray crystallography and biochemical assays to suggest that Lys33 initiates nucleophilic attack of the propeptide by deprotonating the Thr1 hydroxyl group and that both residues together with Asp17 are part of a catalytic triad. Substitution of Thr1 by Cys disrupts the interaction with Lys33 and inactivates the proteasome. Although a Thr1Ser mutant is active, it is less efficient compared with wild type because of the unfavourable orientation of Ser1 towards incoming substrates. This work provides insights into the basic mechanism of proteolysis and propeptide autolysis, as well as the evolutionary pressures that drove the proteasome to become a threonine protease.

1 October 2017 in Structure
Verified
Journal Article
Closed access
EHEva Huber
Eva Huber
MGMichael Groll
Michael Groll

1 February 2015 in Structure
Verified
Journal Article
Closed access
EHEva Huber
Eva Huber
WHWolfgang Heinemeyer
Wolfgang Heinemeyer
MGMichael Groll
Michael Groll

20 January 2014 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
DSDaniel Scharf
Daniel Scharf
MGMichael Groll
Michael Groll
AHAndreas Habel
Andreas Habel
HTHeinekamp Thorsten
Heinekamp Thorsten
CHChristian Hertweck
Christian Hertweck
EHEva Huber
Eva Huber

15 September 2022 in ChemBioChem
Verified
Journal Article
Open access
EHEva Huber
Eva Huber
Epipolythiodioxopiperazines (ETPs) are fungal secondary metabolites that share a 2,5‐diketopiperazine scaffold built from two amino acids and bridged by a sulfide moiety. Modifications of the core and the amino acid side chains, for example by methylations, acetylations, hydroxylations, prenylations, halogenations, cyclizations, and truncations create the structural diversity of ETPs and contribute to their biological activity. However, the key feature responsible for the bioactivities of ETPs is their sulfide moiety. Over the last years, combinations of genome mining, reverse genetics, metabolomics, biochemistry, and structural biology deciphered principles of ETP production. Sulfurization via glutathione and uncovering of the thiols followed by either oxidation or methylation crystallized as fundamental steps that impact expression of the biosynthesis cluster, toxicity and secretion of the metabolite as well as self‐tolerance of the producer. This article showcases structure and activity of prototype ETPs such as gliotoxin and discusses the current knowledge on the biosynthesis routes of these exceptional natural products.